General Counsel · NovoCure Ltd (NVCR)

Todd Longsworth

A named executive officer of NovoCure in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$5,236,783

Salary $480,000Stock awards $3,166,558

FY2020: $5,149,372

4th of 5 named executive officers at NovoCure by FY2021 total.

5 named officers on file for NovoCure, FY2021

Todd Longsworth’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • NVCR’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how NovoCure’s whole pay program stands against its peers

  • NovoCure’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NVCR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2022 (DEF 14A).

Free

Get Todd Longsworth’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Todd Longsworth compensation by year

NovoCure Summary Compensation Table · all 2 fiscal years held
In US dollars, as NovoCure reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$437,500$480,000
Bonus$300,000$0
Stock awards$2,666,583$3,166,558
Option awards$1,328,550$1,581,525
Non-equity incentive$405,000$0
Pension and deferred compensation$0$0
All other$11,739$8,700
Total$5,149,372$5,236,783

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NovoCure Ltd DEF 14A filed April 25, 2022, accession 0001645113-22-000041, and prior-year filings. Open the filing on EDGAR.

How this page was built: the NovoCure Ltd filed document, accession 0001645113-22-000041. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2022.

$5.1M
$5.2M
FY20
FY21
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
PSU19,220$1,443,038—
PSU13,857$1,040,384—
RSU12,813$962,000—
RSU10,342$776,477—
RSU5,456$409,636—
Option29,320—$47.56
Option20,000—$47.56
Option30,413—$21.15

Per the Outstanding Equity Awards at Fiscal Year-End table in NovoCure Ltd's FY2021 proxy; value at the fiscal year-end close, as the company printed it.

NovoCure’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Wilhelmus GroenhuysenChief Operating Officer$6,386,961
Pritesh ShahChief Commercial Officer$5,506,894
Ashley CordovaChief Financial Officer$5,484,444
Todd Longsworth · this pageGeneral Counsel$5,236,783
Asaf DanzigerChief Executive Officer$1,179,283

The full NovoCure compensation record

free company brief

This page is one person within NovoCure's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the NovoCure proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NovoCure's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Todd Longsworth's compensation dossier · One-time report. No refunds.